Prosecution Insights
Last updated: November 11, 2026
Application No. 18/428,903

APPARATUS AND METHOD FOR CANNULATION OF VASCULAR ACCESS VESSEL

Final Rejection §112
Filed
Jan 31, 2024
Priority
Oct 30, 2018 — divisional of 11/925,781
Examiner
FREDRICKSON, COURTNEY B
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Innavasc Medical Inc.
OA Round
4 (Final)
75%
Grant Probability
Favorable
5-6
OA Rounds
4m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allowance Rate
311 granted / 413 resolved
+5.3% vs TC avg
Strong +30% interview lift
Without
With
+29.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
44 currently pending
Career history
465
Total Applications
across all art units

Statute-Specific Performance

§101
1.6%
-38.4% vs TC avg
§103
40.9%
+0.9% vs TC avg
§102
19.3%
-20.7% vs TC avg
§112
31.1%
-8.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 413 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment This office action is responsive to the amendment filed on September 24, 2026. As directed by the amendment: claim 1 has been amended and claims 19-21 have been added. Thus, claims 1-4, 6-14, and 16-21 are presently pending in this application. Response to Arguments Applicant’s arguments, filed September 24, 2026, with respect to the rejection(s) of claim(s) 1 under 35 U.S.C 103 have been fully considered and are persuasive, specifically in regards to Rowe not teaching or disclosing the newly added limitations regarding the boundary lines. Therefore, the rejection has been withdrawn and most of the claims are allowed. However, the examiner finds that new claim 21 raises new matter issues, discussed in further detail below. The examiner notes that attempts to contact Applicant to resolve this remaining issue were unsuccessful. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claim 21 is rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Regarding claim 21, the claim is drawn to zone identifiers within each of the at least four cannulation zones. The originally filed disclosure does not provide sufficient support for such an amendment. The claim is dependent on claim 1 which is drawn to a template having a single opening with a plurality of boundary lines spanning the opening to define a plurality of zones with first and second boundary lines overlapping. Fig. 2 shows such a configuration and additionally shows zone identifiers 50a-l. However, these identifiers are shown to be adjacent the cannulation zones and not within the cannulation zones as presented claimed. Allowable Subject Matter Claims 1-4, 6-14, and 16-20 are allowed over the prior art of record. The following is an examiner’s statement of reasons for allowance: The claims in this application are allowed because the prior art of record fails to disclose either singly or in combination the claimed kit. The closest prior art of record is Rowe (US 20180185059). Regarding independent claim 1, Rowe fails to teach among all the limitations or render obvious the plurality of boundary lines including a first boundary line spanning the single opening in a first direction and a second boundary line spanning the single opening in a second direction such that the first boundary line and the second boundary line overlap, in combination with the total structure and function as claimed. As discussed in previous rejections, Rowe teaches a template (apparatus 200 in fig. 3C) which comprises a single opening (paragraph 64 discloses holes/notches in the edge of the template with this collection of holes/notches forming a "single opening") and including a plurality of boundary lines spanning the single opening (paragraph 64 discloses that the holes/notches are formed in the template so that the material of the template spans the opening formed by the collection of notches/holes to separate the single opening into a plurality of zones with each zone being an individual notch/hole). The examiner notes that the notches/holes, equated to the claimed “boundary lines” are not shown in the drawing. Additionally, the cannulation zones defined by Rowe are arranged linearly and along the edge of the template (zones defined by markings 210 in fig. 3C) so that it is understood that the boundary lines of Rowe would not overlap in the claimed manner. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to COURTNEY FREDRICKSON whose telephone number is (571)270-7481. The examiner can normally be reached Monday-Friday (9 AM - 5 PM EST). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, BHISMA MEHTA can be reached at 571-272-3383. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /COURTNEY FREDRICKSON/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Show 2 earlier events
Mar 23, 2026
Response Filed
Apr 07, 2026
Final Rejection mailed — §112
Jun 03, 2026
Response after Non-Final Action
Jul 06, 2026
Request for Continued Examination
Jul 09, 2026
Response after Non-Final Action
Jul 14, 2026
Non-Final Rejection mailed — §112
Sep 24, 2026
Response Filed
Oct 27, 2026
Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12773545
NEEDLELESS CONNECTOR HAVING CHECK VALVE WITH ASYMMETRIC VALVE DESIGN AND PRIMARY SEAL SUPPORT
5y 5m to grant Granted Oct 27, 2026
Patent 12773483
BREAST PUMP
3y 6m to grant Granted Oct 27, 2026
Patent 12766289
DOUBLE-LUMEN CATHETER
4y 10m to grant Granted Oct 20, 2026
Patent 12766076
ENTERAL FEEDING PUMP DOCKING STATION HAVING INTEGRATED FLUSH MODULE
3y 4m to grant Granted Oct 20, 2026
Patent 12766035
Surgical System Priming With Pressure Calibration
2y 10m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
75%
Grant Probability
99%
With Interview (+29.7%)
3y 1m (~4m remaining)
Median Time to Grant
High
PTA Risk
Based on 413 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month